NIH-funded research P01 program project

Investigating blood complications caused by Babesia infections

Official title: Hemolytic Complications in Babesia Infections

Funded at New York Blood Center · NIH-10880426 · Data updated 2026-11-12

This study is looking at how Babesia infections can make things worse for people with sickle cell disease by causing more blood problems, and it hopes to find new ways to help treat these issues.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionNew York Blood Center
NIH-funded
Lab location1 site (New York, United States)
Project startJuly 20, 2020
Project endJune 30, 2025
Funding year2024
Award (this year)$656,618
NIH project number5P01HL149626-05
Project IDNIH-10880426 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with Babesia infections, particularly those with sickle cell disease.

Less likely to help

Patients who do not have Babesia infections or related hemolytic complications may not benefit from this research.

What this research studies

This research focuses on understanding how Babesia infections lead to hemolytic complications, particularly in patients with sickle cell disease (SCD). It examines the role of extracellular vesicles produced by both the Babesia parasite and the host's immune response, which may contribute to increased hemolysis and anemia. By analyzing these mechanisms, the research aims to uncover the underlying causes of severe complications in infected patients, which could inform better treatment strategies. The study also seeks to draw parallels with other infectious diseases that cause similar blood-related issues.

Why it matters

Potential benefit: If successful, this research could lead to improved management and treatment of hemolytic complications in patients with Babesia infections and potentially other infectious diseases.

How similar studies have gone: Previous research has shown that understanding pathogen-derived extracellular vesicles can provide insights into the pathogenesis of various infectious diseases, suggesting that this approach may yield valuable findings.

Where this research is happening

  • New York Blood Center
    New York, United States
    Active

Researchers

  • Principal investigator: Lobo, Cheryl Ann — New York Blood Center
  • Study coordinator: Lobo, Cheryl Ann

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.